共有 50 笔近期内部人交易记录记录,涉及 Axcella Health Inc. (AXLA), 包括 33 笔买入 和 12 笔卖出. 内部人买入总额为 $40.59M 内部人卖出总额为 $456.1K.
近期活跃的重要内部人包括 Koziel Margaret, Hinshaw William, Fehlner Paul. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — AXLA
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2023-03-01 |
Koziel Margaret |
Chief Medical Officer |
知情卖出 |
679 |
$0.58 |
$393.82 |
24,883 |
| 2023-02-17 |
Hinshaw William |
President & CEO |
限制性股票授予 (RSU) |
275,000 |
$0.68 |
$185.87K |
275,000 |
| 2023-02-17 |
Fehlner Paul |
SVP & Chief Legal Officer |
限制性股票授予 (RSU) |
70,000 |
$0.68 |
$47.31K |
70,000 |
| 2023-02-17 |
Koziel Margaret |
Chief Medical Officer |
限制性股票授予 (RSU) |
70,000 |
$0.68 |
$47.31K |
70,000 |
| 2023-02-10 |
Fehlner Paul |
SVP & Chief Legal Officer |
知情买入 |
5,221 |
$0.66 |
$3.45K |
58,081 |
| 2022-11-16 |
Rosiello Robert L. |
Director |
限制性股票授予 (RSU) |
40,000 |
- |
- |
40,000 |
| 2022-11-16 |
Nissen Torben Straight |
Director |
限制性股票授予 (RSU) |
40,000 |
- |
- |
40,000 |
| 2022-10-19 |
Hinshaw William |
President & CEO |
知情卖出 |
16,000 |
$1.56 |
$25.03K |
82,012 |
| 2022-10-17 |
Hinshaw William |
President & CEO |
限制性股票授予 (RSU) |
50,000 |
- |
- |
98,012 |
| 2022-10-13 |
Nestle Sa |
Director |
知情买入 |
3,658,536 |
$1.64 |
$6M |
11,105,438 |
| 2022-10-13 |
Afeyan Noubar |
Director |
知情买入 |
3,048,780 |
$1.64 |
$5M |
3,048,780 |
| 2022-10-13 |
Flagship Pioneering Inc. |
Director |
未知 |
- |
- |
- |
3,048,780 |
| 2022-10-13 |
Flagship Ventures Fund Iv General Partner Llc |
10 Percent Owner |
知情买入 |
3,048,780 |
$1.64 |
$5M |
3,048,780 |
| 2022-10-13 |
Societe Des Produits Nestle S.a. |
10 Percent Owner |
知情买入 |
3,658,536 |
$1.64 |
$6M |
11,105,438 |
| 2022-10-10 |
Rosiello Robert L. |
Director |
未知 |
- |
- |
- |
- |
| 2022-10-10 |
Nissen Torben Straight |
Director |
未知 |
- |
- |
- |
- |
| 2022-06-01 |
Koziel Margaret |
Chief Medical Officer |
知情卖出 |
590 |
$2.01 |
$1.19K |
26,109 |
| 2022-05-19 |
Rosenblatt Michael |
Director |
处置 |
5,428 |
$13.83 |
$75.07K |
- |
| 2022-05-19 |
Rosenblatt Michael |
Director |
限制性股票授予 (RSU) |
40,000 |
$1.70 |
$68K |
40,000 |
| 2022-05-19 |
Baird William D Iii |
Director |
限制性股票授予 (RSU) |
20,000 |
$1.70 |
$34K |
20,000 |
| 2022-05-19 |
Sohn Catherine A. |
Director |
限制性股票授予 (RSU) |
20,000 |
$1.70 |
$34K |
20,000 |
| 2022-05-19 |
Pisano Gary P. |
Director |
限制性股票授予 (RSU) |
20,000 |
- |
- |
20,000 |
| 2022-05-19 |
Rondinone Cristina |
Director |
限制性股票授予 (RSU) |
20,000 |
$1.70 |
$34K |
20,000 |
| 2022-05-19 |
Hendrix Martin |
Director |
未知 |
- |
- |
- |
- |
| 2022-05-19 |
Hendrix Martin |
Director |
限制性股票授予 (RSU) |
40,000 |
- |
- |
40,000 |
| 2022-05-19 |
Sekhri Paul J |
Director |
未知 |
- |
- |
- |
- |
| 2022-05-19 |
Sekhri Paul J |
Director |
限制性股票授予 (RSU) |
40,000 |
$1.70 |
$68K |
40,000 |
| 2022-05-19 |
Epstein David R |
Director |
限制性股票授予 (RSU) |
47,059 |
- |
- |
209,756 |
| 2022-03-17 |
Epstein David R |
Director |
期权行权(卖出) |
1,535 |
- |
- |
- |
| 2022-03-16 |
Nestle Sa |
Director |
知情买入 |
3,141,361 |
$1.91 |
$6M |
7,446,902 |
| 2022-03-16 |
Societe Des Produits Nestle S.a. |
10 Percent Owner |
知情买入 |
3,141,361 |
$1.91 |
$6M |
7,446,902 |
| 2022-03-16 |
Afeyan Noubar |
Director |
知情买入 |
1,579,843 |
$1.91 |
$3.02M |
4,465,866 |
| 2022-03-16 |
Crane Robert |
Chief Financial Officer |
知情买入 |
39,267 |
$1.91 |
$75K |
39,267 |
| 2022-03-16 |
Epstein David R |
Director |
知情买入 |
26,178 |
$1.91 |
$50K |
161,162 |
| 2022-03-16 |
Flagship Ventures Fund Iv General Partner Llc |
10 Percent Owner |
知情买入 |
947,905 |
$1.91 |
$1.81M |
2,004,657 |
| 2022-03-16 |
Hinshaw William |
President & CEO |
知情买入 |
13,089 |
$1.91 |
$25K |
48,012 |
| 2022-03-16 |
Fehlner Paul |
SVP & Chief Legal Officer |
知情买入 |
10,471 |
$1.91 |
$20K |
20,802 |
| 2022-03-01 |
Koziel Margaret |
Chief Medical Officer |
知情卖出 |
553 |
$1.86 |
$1.03K |
26,699 |
| 2022-02-18 |
Epstein David R |
Director |
期权行权(卖出) |
1,534 |
- |
- |
1,535 |
| 2022-02-08 |
Hinshaw William |
President & CEO |
限制性股票授予 (RSU) |
100,000 |
$5.00 |
$500K |
100,000 |
| 2022-02-08 |
Fehlner Paul |
SVP & Chief Legal Officer |
限制性股票授予 (RSU) |
70,000 |
$1.63 |
$114.1K |
70,000 |
| 2022-02-08 |
Schecter Alison D. |
President - Research & Dev. |
限制性股票授予 (RSU) |
56,000 |
$1.63 |
$91.28K |
56,000 |
| 2022-02-08 |
Dean Virginia R |
SVP, Chief People Officer |
限制性股票授予 (RSU) |
71,400 |
$1.63 |
$116.38K |
71,400 |
| 2022-02-08 |
Koziel Margaret |
Chief Medical Officer |
限制性股票授予 (RSU) |
33,397 |
$1.63 |
$54.44K |
33,397 |
| 2022-02-08 |
Crane Robert |
Chief Financial Officer |
处置 |
200,000 |
$1.63 |
$326K |
- |
| 2022-01-31 |
Hinshaw William |
President and CEO |
知情卖出 |
16,590 |
$1.65 |
$27.39K |
33,410 |
| 2022-01-28 |
Hinshaw William |
President and CEO |
期权行权(卖出) |
50,000 |
- |
- |
- |
| 2022-01-18 |
Epstein David R |
Director |
期权行权(卖出) |
1,535 |
- |
- |
3,069 |
| 2021-12-17 |
Epstein David R |
Director |
期权行权(卖出) |
1,535 |
- |
- |
4,604 |
| 2021-12-10 |
Koziel Margaret |
Chief Medical Officer |
限制性股票授予 (RSU) |
75,000 |
$2.60 |
$195K |
75,000 |
■ 知情交易 — 公开市场买卖(最具参考价值)
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期